Attached files
| file | filename |
|---|---|
| EX-4.4 - EX-4.4 - Sorrento Therapeutics, Inc. | srne-ex44_20141231829.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Sorrento Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - EX-31.1 - Sorrento Therapeutics, Inc. | srne-ex311_201412318.htm |
| EX-23.1 - EX-23.1 - Sorrento Therapeutics, Inc. | srne-ex231_201412317.htm |
| EX-31.2 - EX-31.2 - Sorrento Therapeutics, Inc. | srne-ex312_201412319.htm |
| EX-32.1 - EX-32.1 - Sorrento Therapeutics, Inc. | srne-ex321_2014123110.htm |
| EX-10.24 - EX-10.24 - Sorrento Therapeutics, Inc. | srne-ex1024_20141231830.htm |
| EX-10.25 - EX-10.25 - Sorrento Therapeutics, Inc. | srne-ex1025_20141231831.htm |
| EX-10.30 - EX-10.30 - Sorrento Therapeutics, Inc. | srne-ex1030_20141231832.htm |
| 10-K - 10-K - Sorrento Therapeutics, Inc. | srne-10k_20141231.htm |
Exhibit 21
Subsidiaries of Registrant
|
|
|
State of |
|
Percentage |
|
|
|
IgDraSol, Inc. |
|
Delaware |
|
|
100 |
% |
|
Concortis Biosystems, Corp. |
|
Delaware |
|
|
100 |
% |
|
Sorrento Therapeutics, Inc. Hong Kong Limited |
|
Hong Kong, China |
|
|
100 |
% |
|
Ark Animal Therapeutics, Inc. |
|
Delaware |
|
|
100 |
% |